Back
Product details:
CAS
1621862-70-1
Purity
95%
CPI-1205 is a Phase I/II agent designed to selectively target the EZH2 component of the polycomb repressor complex (PRC). It is a well designed, and well described pharmacological tool with well defined pharmacokinetic properties.
Properties
Name
CPI-1205
Smiles
COC=1C=C(C)NC(=O)C1CNC(=O)C2=C(C)N([C@H](C)C3CCN(CC(F)(F)F)CC3)C=4C=CC=CC24
Targets
Please log in to see this information
Target name
Target pX
Target action
doi
CPI-1205 | lirametostat
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$85
2 mg
$85
5 mg
$154
10 mg
$266
15 mg
$322
20 mg
$379
25 mg
$460
30 mg
$542
35 mg
$624
40 mg
$706
45 mg
$757
50 mg
$808
75 mg
$1074
100 mg
Get a quoteQuantity
1
Total amount
$ 154
CPI-1205 | lirametostat
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.